Recombumin® Prime | Recombinant Human Albumin from Albumedix, now a part of Sartorius

Recombumin® Prime is a 20 % (w/v) recombinant human albumin product produced in Saccharomyces cerevisiae and formulated with polysorbate 80 and octanoate. The world’s only USP-NF compliant recombinant human albumin, Recombumin® Prime is high quality, consistent, and supports high performance across a range of unit operations. Albumin, a ubiquitous protein, has evolved to support a range of biological processes through its physicochemical and biological properties. Recombumin® Prime 20 % (w/v) is a high-quality, human and animal origin free, recombinant human albumin that supports your development of consistent, high performing processes. Manufactured in an ICH Q7 cGMP facility, Recombumin® Prime offers your process batch-to-batch consistency and predictable performance. Utilized in FDA, EMEA and MHRA approved products, early and late-stage clinical biopharmaceutical candidates, and as a coating for marketed high-class medical devices, Recombumin® Prime has excellent market exposure. With an extensive regulatory package and drug master files registered in key markets, Recombumin® Prime is a solution for those developing high-quality products, that demand quality and consistent raw materials. Owing to the variability of performance that can be experienced when using different albumin sources and formulations, Sartorius also offers Recombumin® Elite a 10 % (w/v) salt-based recombinant human albumin formulation. When requesting a sample get in touch with our experts to discuss what the best formulation for your process would be. Our Recombumin® portfolio results from four decades of research and development focused on recombinant human albumin enabled solutions. The formulation of your albumin really matters, as the manufacturing process and the ligands associated with albumin drive differential performance. Use the experience and know-how of our Sartorius team to help make your project a success!